209 related articles for article (PubMed ID: 25111004)
21. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N
Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
[TBL] [Abstract][Full Text] [Related]
22. Screening and differential diagnosis of renal light chain-associated diseases.
Gerth J; Sachse A; Busch M; Illner N; Muegge LO; Gröne HJ; Wolf G
Kidney Blood Press Res; 2012; 35(2):120-8. PubMed ID: 22056791
[TBL] [Abstract][Full Text] [Related]
23. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis.
Bergesio F; Ciciani AM; Santostefano M; Brugnano R; Manganaro M; Palladini G; Di Palma AM; Gallo M; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2007 Jun; 22(6):1608-18. PubMed ID: 17395661
[TBL] [Abstract][Full Text] [Related]
24. Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry.
Olson LJ; Gertz MA; Edwards WD; Li CY; Pellikka PA; Holmes DR; Tajik AJ; Kyle RA
N Engl J Med; 1987 Sep; 317(12):738-42. PubMed ID: 3627183
[TBL] [Abstract][Full Text] [Related]
25. [Renal amyloidosis].
Kościelska M; Shebani Z; Matuszkiewicz-Rowińska J
Przegl Lek; 2013; 70(4):205-10. PubMed ID: 23991559
[TBL] [Abstract][Full Text] [Related]
26. Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience.
Lim AY; Lee JH; Jung KS; Gwag HB; Kim DH; Kim SJ; Lee GY; Kim JS; Kim HJ; Lee SY; Lee JE; Jeon ES; Kim K
Korean J Intern Med; 2015 Jul; 30(4):496-505. PubMed ID: 26161016
[TBL] [Abstract][Full Text] [Related]
27. [Multisystemic amyloidosis. Clinical study of 39 patients in Lebanon].
Saba M; Tohmé A; Abadjian G; Haddad F; Ghayad E
Presse Med; 2005 May; 34(9):640-6. PubMed ID: 15988337
[TBL] [Abstract][Full Text] [Related]
28. Kidney disease and plasma cell dyscrasias: ambiguous cases solved by serum free light chain dimerization analysis.
Kukuy O; Kaplan B; Golderman S; Volkov A; Duek A; Leiba M; Ben-Zvi I; Livneh A
Clin Exp Nephrol; 2019 Jun; 23(6):763-772. PubMed ID: 30734185
[TBL] [Abstract][Full Text] [Related]
29. [Case of AL amyloidosis associated with a remarkable histological progress in a short period].
Kadoya H; Namba T; Matsuda J; Yamamoto T; Takeji M; Yamauchi A
Nihon Jinzo Gakkai Shi; 2010; 52(5):590-4. PubMed ID: 20715592
[TBL] [Abstract][Full Text] [Related]
30. [Renal manifestations of light chain associated diseases - epidemiology and prognosis].
Gerth J; Sigusch H; Illner N; Busch M; Muegge LO; Lehmann T; Wolf G
Dtsch Med Wochenschr; 2013 Feb; 138(7):305-12. PubMed ID: 23392999
[TBL] [Abstract][Full Text] [Related]
31. Light-chain (AL) amyloidosis: diagnosis and treatment.
Sanchorawala V
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1331-41. PubMed ID: 17699366
[TBL] [Abstract][Full Text] [Related]
32. Clinical and pathological features of renal amyloidosis: an analysis of 32 patients in a single Chinese centre.
Qu Z; Zheng X; Wang SX; Ao J; Zhou FD; Chen M; Liu G
Nephrology (Carlton); 2010 Feb; 15(1):102-7. PubMed ID: 20377777
[TBL] [Abstract][Full Text] [Related]
33. Clinical recognition of Al type amyloidosis of the luminal gastrointestinal tract.
James DG; Zuckerman GR; Sayuk GS; Wang HL; Prakash C
Clin Gastroenterol Hepatol; 2007 May; 5(5):582-8. PubMed ID: 17428737
[TBL] [Abstract][Full Text] [Related]
34. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease.
Kaplan B; Ramirez-Alvarado M; Sikkink L; Golderman S; Dispenzieri A; Livneh A; Gallo G
Br J Haematol; 2009 Mar; 144(5):705-15. PubMed ID: 19076171
[TBL] [Abstract][Full Text] [Related]
35. The spectrum of monoclonal immunoglobulin deposition disease associated with immunocytic dyscrasias.
Gallo G; Picken M; Buxbaum J; Frangione B
Semin Hematol; 1989 Jul; 26(3):234-45. PubMed ID: 2506646
[TBL] [Abstract][Full Text] [Related]
36. Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining.
Paueksakon P; Fogo AB; Sethi S
Hum Pathol; 2014 Jul; 45(7):1445-50. PubMed ID: 24792621
[TBL] [Abstract][Full Text] [Related]
37. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic delay and characterization of the clinical prodrome in AL amyloidosis among 1523 US adults diagnosed between 2001 and 2019.
Hester LL; Gifkins DM; M Bellew K; Vermeulen J; Schecter JM; Strony J; Dishy V; Weiss BM
Eur J Haematol; 2021 Oct; 107(4):428-435. PubMed ID: 34137077
[TBL] [Abstract][Full Text] [Related]
39. Amyloidosis with IgM monoclonal gammopathies.
Gertz MA; Kyle RA
Semin Oncol; 2003 Apr; 30(2):325-8. PubMed ID: 12720162
[TBL] [Abstract][Full Text] [Related]
40. Heart transplantation for restrictive cardiomyopathy: development of cardiac amyloidosis in preexisting monoclonal gammopathy.
Deng M; Park JW; Roy-Chowdury R; Knieriem HJ; Reinhard U; Heinrich KW
J Heart Lung Transplant; 1992; 11(1 Pt 1):139-41. PubMed ID: 1540601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
